Evidence map›Paper›PMID 32229617›Full record

ArticleInfection and immunity2020

Combination of

Somaditya Dey, Debarati Mukherjee, Sirin Salma Sultana, Suvadip Mallick, Aritri Dutta, Joydip Ghosh, Aabid Hussain, Biswajyoti Sarkar, Supratim Mandal, Pradyumna Patra and 2 more

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Frontiers in immunology · 2024
    Review
  3. Article
  4. The level of interleukin-17, 23, and gamma interferon in cutaneous leishmaniasis patients before and after intra lesion treatment.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  5. Article
  6. Article
  7. Deletion of Glutamine Synthetase Gene Disrupts the Survivability and Infectivity ofFrontiers in cellular and infection microbiology · 2021
    Article
  8. Article
  9. Indian dermatology online journal
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Somaditya DeyCellular Immunology and Experimental Therapeutics Laboratory, Department of Zoology, West Bengal State University, Barasat, West Bengal, India.
Debarati MukherjeeCellular Immunology and Experimental Therapeutics Laboratory, Department of Zoology, West Bengal State University, Barasat, West Bengal, India.
Sirin Salma SultanaCellular Immunology and Experimental Therapeutics Laboratory, Department of Zoology, West Bengal State University, Barasat, West Bengal, India.
Suvadip MallickCellular Immunology and Experimental Therapeutics Laboratory, Department of Zoology, West Bengal State University, Barasat, West Bengal, India.
Aritri DuttaCellular Immunology and Experimental Therapeutics Laboratory, Department of Zoology, West Bengal State University, Barasat, West Bengal, India.
Joydip GhoshCellular Immunology and Experimental Therapeutics Laboratory, Department of Zoology, West Bengal State University, Barasat, West Bengal, India.
Aabid HussainCellular Immunology and Experimental Therapeutics Laboratory, Department of Zoology, West Bengal State University, Barasat, West Bengal, India.
Biswajyoti SarkarCellular Immunology and Experimental Therapeutics Laboratory, Department of Zoology, West Bengal State University, Barasat, West Bengal, India.
Supratim MandalCellular Immunology and Experimental Therapeutics Laboratory, Department of Zoology, West Bengal State University, Barasat, West Bengal, India.
Pradyumna PatraCellular Immunology and Experimental Therapeutics Laboratory, Department of Zoology, West Bengal State University, Barasat, West Bengal, India.
Bhaskar SahaNational Centre for Cell Science, Pune, Maharashtra, India.
Chiranjib PalCellular Immunology and Experimental Therapeutics Laboratory, Department of Zoology, West Bengal State University, Barasat, West Bengal, India chiranjibpal.zoology@wbsu.ac.in cpcu.immunology@gmail.com.ORCID 0000-0002-0724-5292
West Bengal State University · INNational Centre for Cell Science · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The major issues in available therapeutic modalities against leishmaniasis are cost, toxicity, and the emergence of drug resistance. The aim of this work was to develop a successful therapeutic adjuvant against drug-resistant

Indexed as

Leishmania donovaniAnimalsCD4-Positive T-LymphocytesCell DifferentiationCombined Modality TherapyDendritic CellsDrug ResistanceHeat-Shock ProteinsHot TemperatureImmunologic MemoryImmunophenotypingInflammation MediatorsInterleukin-6Leishmaniasis, VisceralMiceMycobacteriumHeat-Shock ProteinsInflammation MediatorsInterleukin-6Protozoan Proteinsdrug-resistantLeishmania donovanimemory T cellspre-DCs and cDCsTh1-Th17therapeutic adjuvantT regulatory cells

Identifiers

PMID32229617
PMCPMC7240079
OpenAlexW3013430989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.